BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34461384)

  • 1. The effect of a hysteroscopic niche resection compared with Levonorgestrel-releasing intrauterine device on postmenstrual spotting in patients with a symptomatic niche in the uterine cesarean scar: A prospective cohort study.
    He X; Yan L; He C; Zhu C; Mol BW; Zhang J; Huirne JAF
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():66-73. PubMed ID: 34461384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing levonorgestrel intrauterine system with hysteroscopic niche resection in women with postmenstrual spotting related to a niche in the uterine cesarean scar: a randomized, open-label, controlled trial.
    Zhang J; Zhu C; Yan L; Wang Y; Zhu Q; He C; He X; Ji S; Tian Y; Xie L; Liang Y; Xia W; Mol BW; Huirne JAF
    Am J Obstet Gynecol; 2023 Jun; 228(6):712.e1-712.e16. PubMed ID: 36935068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing levonorgestrel intrauterine system versus hysteroscopic resection in patients with postmenstrual spotting related to a niche in the caesarean scar (MIHYS NICHE trial): protocol of a randomised controlled trial.
    He C; He X; Liang Y; Sun T; Yan L; Zhu C; Zhao X; Xie L; Mol BW; Zhang J; Huirne JAF
    BMJ Open; 2021 Aug; 11(8):e045770. PubMed ID: 34462279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J; Lähteenmäki P
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hysteroscopic resection of a uterine caesarean scar defect (niche) in women with postmenstrual spotting: a randomised controlled trial.
    Vervoort A; van der Voet LF; Hehenkamp W; Thurkow AL; van Kesteren P; Quartero H; Kuchenbecker W; Bongers M; Geomini P; de Vleeschouwer L; van Hooff M; van Vliet H; Veersema S; Renes WB; Oude Rengerink K; Zwolsman SE; Brölmann H; Mol B; Huirne J
    BJOG; 2018 Feb; 125(3):326-334. PubMed ID: 28504857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating resectoscopy and the levonorgestrel intrauterine system for intermenstrual bleeding associated with cesarean scar defects: A retrospective study of treatment outcomes.
    Huang SY; Chen YY; Tsai CC; Lin H; Ou YC
    J Obstet Gynaecol Res; 2024 Feb; 50(2):253-261. PubMed ID: 37990626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suture fixation of levonorgestrel-releasing intrauterine device using the hysteroscopic cold-knife surgery system: an original method in treatment of adenomyosis.
    Zhu L; Yang X; Cao B; Tang S; Tong J
    Fertil Steril; 2021 Oct; 116(4):1191-1193. PubMed ID: 34238576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HysNiche trial: hysteroscopic resection of uterine caesarean scar defect (niche) in patients with abnormal bleeding, a randomised controlled trial.
    Vervoort AJ; Van der Voet LF; Witmer M; Thurkow AL; Radder CM; van Kesteren PJ; Quartero HW; Kuchenbecker WK; Bongers MY; Geomini PM; de Vleeschouwer LH; van Hooff MH; van Vliet HA; Veersema S; Renes WB; van Meurs HS; Bosmans J; Oude Rengerink K; Brölmann HA; Mol BW; Huirne JA
    BMC Womens Health; 2015 Nov; 15():103. PubMed ID: 26563197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
    Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
    Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal intrauterine devices.
    Rybo G; Andersson K; Odlind V
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Women With an Endometrial Polyp and Heavy Menstrual Bleeding: A Levonorgestrel-Releasing Intrauterine Device or Hysteroscopic Polypectomy?
    van Dijk MM; van Hanegem N; de Lange ME; Timmermans A
    J Minim Invasive Gynecol; 2015; 22(7):1153-62. PubMed ID: 26151760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
    Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
    Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levonorgestrel-Releasing Intrauterine Device Use Can Be a Treatment Option in Symptomatic Patients with Isthmocele.
    Ketenci Gencer F; Dincgez B; Yuksel S
    Reprod Sci; 2022 Oct; 29(10):2977-2982. PubMed ID: 35610461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability.
    Tang GW; Lo SS
    Contraception; 1995 Apr; 51(4):231-5. PubMed ID: 7796588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S; Hickey M; Chin J; Su HI
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.